高级检索
当前位置: 首页 > 详情页

Identification of microRNAs associated with medullary thyroid carcinoma by bioinformatics analyses

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Capital Med Univ, Beijing Tongren Hosp, Dept Otorhinolaryngol Head & Neck Surg, 8 Chongwenmennei St, Beijing 100730, Peoples R China [2]Guangdong 2 Prov Peoples Hosp, Dept Otorhinolaryngol Head & Neck Surg, Guangzhou 510317, Guangdong, Peoples R China
出处:
ISSN:

关键词: medullary thyroid carcinoma differentially expressed microRNAs transcription factor target gene

摘要:
The present study aimed to investigate the microRNA (miRNA) profile in human medullary thyroid carcinoma (MTC) tissue. The GSE40807 data profile was downloaded from the Gene Expression Omnibus database. Following preprocessing, differentially expressed microRNAs (DEMs) between MTC and healthy tissues were identified. Based on the obtained DEMs, transcription factor (TF) -miRNA and miRNA-target gene regulatory association pairs were predicted. Finally, functional enrichment analysis was performed on target genes of DEMs. Fifteen upregulated and 17 downregulated DEMs were identified. In the constructed TF-miRNA regulatory network, hsa-miR-9-5p was regulated by 9 TFs and hsa-miR-1 was regulated by 8 TFs. TFs of nuclear factor of. light polypeptide gene enhancer in B-cells 1 (NF-kappa B1) and v-myc avian myelocytomatosis viral oncogene homolog (MYC) regulated 4 and 3 DEMs, respectively. In the miRNA-target gene regulatory network, hsa-miR-1, hsa-miR-9-5p, hsa-miR-96-5p and hsa-miR-590-5p were most upregulated. The target genes of these 4 miRNAs were primarily enriched in the mitogen activated protein kinase (MAPK) signaling pathway. Therefore, MAPK signaling pathway may serve important roles in MTC progression. In conclusion, the DEMs hsa-miR-1 and hsa-miR-9-5p, and TFs of NF-kappa B1 and MYC may be used as biomarkers for the diagnosis and treatment of MTC.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2016]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验 4 区 肿瘤学
最新[2023]版:
大类 | 3 区 医学
小类 | 4 区 医学:研究与实验 4 区 肿瘤学
JCR分区:
出版当年[2015]版:
Q3 MEDICINE, RESEARCH & EXPERIMENTAL Q4 ONCOLOGY
最新[2023]版:
Q2 ONCOLOGY Q2 MEDICINE, RESEARCH & EXPERIMENTAL

影响因子: 最新[2023版] 最新五年平均 出版当年[2015版] 出版当年五年平均 出版前一年[2014版] 出版后一年[2016版]

第一作者:
第一作者机构: [1]Capital Med Univ, Beijing Tongren Hosp, Dept Otorhinolaryngol Head & Neck Surg, 8 Chongwenmennei St, Beijing 100730, Peoples R China [2]Guangdong 2 Prov Peoples Hosp, Dept Otorhinolaryngol Head & Neck Surg, Guangzhou 510317, Guangdong, Peoples R China
通讯作者:
通讯机构: [1]Capital Med Univ, Beijing Tongren Hosp, Dept Otorhinolaryngol Head & Neck Surg, 8 Chongwenmennei St, Beijing 100730, Peoples R China [*1]Department of Otorhinolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, 8 Chongwenmennei Street, Dongcheng, Beijing 100730, P.R. China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:21205 今日访问量:0 总访问量:1219 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)